475 related articles for article (PubMed ID: 29089175)
1. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
2. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S
PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
[TBL] [Abstract][Full Text] [Related]
6. Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1
Kettwig M; Klemp H; Nessler S; Streit F; Krätzner R; Rosewich H; Gärtner J
J Inherit Metab Dis; 2021 Sep; 44(5):1174-1185. PubMed ID: 33855724
[TBL] [Abstract][Full Text] [Related]
7. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
Haynes CA; De Jesús VR
Clin Chim Acta; 2012 Aug; 413(15-16):1217-21. PubMed ID: 22503909
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
[TBL] [Abstract][Full Text] [Related]
9. Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy.
Wu C; Iwamoto T; Igarashi J; Miyajima T; Hossain MA; Yanagisawa H; Akiyama K; Shintaku H; Eto Y
Mol Genet Metab Rep; 2017 Sep; 12():115-118. PubMed ID: 28725571
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
[TBL] [Abstract][Full Text] [Related]
11. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
[TBL] [Abstract][Full Text] [Related]
12. Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat MD; Chandra SR
Clin Chim Acta; 2019 Aug; 495():167-173. PubMed ID: 30980791
[TBL] [Abstract][Full Text] [Related]
13. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
[TBL] [Abstract][Full Text] [Related]
14. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
[TBL] [Abstract][Full Text] [Related]
15. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
[TBL] [Abstract][Full Text] [Related]
17. Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy.
Natarajan A; Christopher R; Palakuzhiyil SV; Chandra SR
Mol Genet Metab Rep; 2021 Mar; 26():100720. PubMed ID: 33552912
[TBL] [Abstract][Full Text] [Related]
18. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
[TBL] [Abstract][Full Text] [Related]
19. Aicardi-Goutières syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy.
Tise CG; Morales JA; Lee AS; Velez-Bartolomei F; Floyd BJ; Levy RJ; Cusmano-Ozog KP; Feigenbaum AS; Ruzhnikov MRZ; Lee CU; Enns GM
Am J Med Genet A; 2021 Jun; 185(6):1848-1853. PubMed ID: 33683010
[TBL] [Abstract][Full Text] [Related]
20. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
